Norinchukin Bank’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-125,159
Closed -$12.4M 518
2019
Q3
$12.4M Buy
125,159
+3,236
+3% +$307K 0.18% 92
2019
Q2
$11.3M Sell
121,923
-49,008
-29% -$4.65M 0.17% 87
2019
Q1
$16.1M Buy
170,931
+5,477
+3% +$479K 0.21% 91
2018
Q4
$10.6M Buy
165,454
+39,497
+31% +$2.92M 0.15% 109
2018
Q3
$11.3M Buy
125,957
+10,093
+9% +$892K 0.15% 102
2018
Q2
$9.2M Buy
115,864
+8,723
+8% +$724K 0.14% 103
2018
Q1
$9.56M Sell
107,141
-37,220
-26% -$3.57M 0.16% 95
2017
Q4
$15.1M Buy
144,361
+4,921
+4% +$555K 0.26% 64
2017
Q3
$20.3M Buy
139,440
+19,082
+16% +$2.6M 0.39% 41
2017
Q2
$15.6M Buy
120,358
+29,957
+33% +$3.67M 0.32% 47
2017
Q1
$11.2M Buy
90,401
+4,024
+5% +$482K 0.24% 67
2016
Q4
$10M Buy
86,377
+5,755
+7% +$641K 0.23% 66
2016
Q3
$8.43M Buy
80,622
+781
+1% +$84.5K 0.2% 73
2016
Q2
$7.88M Buy
79,841
+336
+0.4% +$34.8K 0.19% 75
2016
Q1
$7.96M Buy
79,505
+3,119
+4% +$321K 0.19% 77
2015
Q4
$9.15M Sell
76,386
-8,530
-10% -$987K 0.23% 69
2015
Q3
$9.19M Buy
84,916
+230
+0.3% +$28.5K 0.24% 66
2015
Q2
$9.8M Sell
84,686
-2,771
-3% -$317K 0.25% 60
2015
Q1
$10.1M Buy
87,457
+29,754
+52% +$3.56M 0.24% 59
2014
Q4
$6.46M Buy
57,703
+23,184
+67% +$2.45M 0.16% 89
2014
Q3
$3.27M Buy
34,519
+4,635
+16% +$418K 0.09% 103
2014
Q2
$2.57M Sell
29,884
-3,718
-11% -$283K 0.08% 107
2014
Q1
$2.35M Buy
33,602
+2,818
+9% +$223K 0.07% 117
2013
Q4
$2.6M Sell
30,784
-110
-0.4% -$8.7K 0.07% 104
2013
Q3
$2.38M Buy
30,894
+2,000
+7% +$140K 0.07% 100
2013
Q2
$1.69M Buy
+28,894
New +$1.74M 0.05% 120

Other funds holding CELG

Norinchukin Bank's CELG Position: Q4 2019 in Review

Norinchukin Bank sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 125,159 shares — an estimated $12.4M sold.

Norinchukin Bank first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $20.3M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Norinchukin Bank reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Norinchukin Bank sold 125,159 Celgene Corp shares in Q4 2019, an estimated $12.4M.
  • Norinchukin Bank first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Norinchukin Bank's Celgene Corp position peaked at $20.3M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Norinchukin Bank's 13F filing for Q4 2019, filed 12 Feb 2020.